Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.60 |
| ▸ | CTSS | P25774 | 2/20 | 0.60 |
| ▸ | CTSB | P07858 | 1/20 | 0.60 |
| ▸ | CTSK | P43235 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | FCER2 | P06734 | 2/20 | 0.53 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | MMP8 | P22894 | 1/20 | 0.51 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2905617 | 1.00 | CTSL (0.60) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL1554667 | 1.00 | CTSL (0.60) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2903642 | 0.93 | CTSL (0.54) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2903014 | 0.93 | CTSL (0.54) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2903010 | 0.93 | CTSL (0.54) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2900002 | 0.90 | TACR1 (0.53) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2900007 | 0.90 | TACR1 (0.53) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2906870 | 0.90 | TACR1 (0.53) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2905746 | 0.87 | CTSL (0.53) | CTSLCTSSCTSBCTSKHDAC8 | |
| SCHEMBL2903098 | 0.87 | CTSL (0.53) | CTSLCTSSCTSBCTSKHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637702-B2 | Derivatives of N-hydroxybenzamide for treating HIV infections | ITALFARMACO S.P.A. (IT) | 2014-01-28 | — | — | US | claimed |
| EP-2490682-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | ITALFARMACO S.p.A. (IT) | 2012-08-29 | — | — | EP | claimed |
| US-20120203014-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | ITALFARMACO S.P.A. (IT) | 2012-08-09 | — | — | US | claimed |
| WO-2011048514-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | ITALFARMACO S.P.A. (IT) | 2011-04-28 | — | — | WO | claimed |
| EP-1763507-B1 | ALPHA-AMINO ACID DERIVATES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 2010-08-11 | — | — | EP | claimed |
| US-7635788-B2 | Alpha-amino acid derivatives with antiinflammatory activity | ITALFARMACO SPA (IT) | 2009-12-22 | — | — | US | claimed |
| US-20080076807-A1 | Alpha-Amino Acid Derivatives with Antiinflammatory Activity | ITALFARMACO SPA (IT) | 2008-03-27 | — | — | US | claimed |
| EP-1763507-A2 | ALPHA-AMINO ACID DERIVATES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO S.p.A. (IT) | 2007-03-21 | — | — | EP | claimed |
| WO-2006003068-A2 | ALPHA-AMINO ACID DERIVATIVES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 2006-01-12 | — | — | WO | claimed |
| US-8637702-B2 | Derivatives of N-hydroxybenzamide for treating HIV infections | ITALFARMACO S.P.A. (IT) | 2014-01-28 | — | — | US | disclosed |
| US-8637702-B2 | Derivatives of N-hydroxybenzamide for treating HIV infections | ITALFARMACO S.P.A. (IT) | 2014-01-28 | — | — | US | disclosed |
| EP-2490682-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | ITALFARMACO S.p.A. (IT) | 2012-08-29 | — | — | EP | disclosed |
| EP-2490682-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | ITALFARMACO S.p.A. (IT) | 2012-08-29 | — | — | EP | disclosed |
| US-20120203014-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | ITALFARMACO S.P.A. (IT) | 2012-08-09 | — | — | US | disclosed |
| WO-2011048514-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | ITALFARMACO S.P.A. (IT) | 2011-04-28 | — | — | WO | disclosed |
| EP-1763507-B1 | ALPHA-AMINO ACID DERIVATES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 2010-08-11 | — | — | EP | disclosed |
| US-7635788-B2 | Alpha-amino acid derivatives with antiinflammatory activity | ITALFARMACO SPA (IT) | 2009-12-22 | — | — | US | disclosed |
| US-20080076807-A1 | Alpha-Amino Acid Derivatives with Antiinflammatory Activity | ITALFARMACO SPA (IT) | 2008-03-27 | — | — | US | disclosed |
| EP-1763507-A2 | ALPHA-AMINO ACID DERIVATES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO S.p.A. (IT) | 2007-03-21 | — | — | EP | disclosed |
| WO-2006003068-A2 | ALPHA-AMINO ACID DERIVATIVES WITH ANTIINFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 2006-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120203014-A1 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS | HDAC1, HDAC4, HDAC5 | CTSL 419/4885CTSS 1137/4885CTSB 230/4885 |
| US-20080076807-A1 | Alpha-Amino Acid Derivatives with Antiinflammatory Activity | TNF, NFKBIA, IFNG | CTSL 321/4885CTSS 1616/4885CTSB 678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.